Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Algorithm-based Screening in Patients With Glycemically Defined New Onset Diabetes to Evaluate Risk for and Earlier Detection of Pancreatic Ductal Adenocarcinoma; Early Detection Initiative (EDI) for Pancreatic Cancer

NCT04662879 is registered in ClinicalTrials.gov with Pancreatic Cancer Action Network as lead sponsor.

NCT NCT04662879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Algorithm-based Screening in Patients With Glycemically Defined New Onset Diabetes to Evaluate Risk for and Earlier Detection of Pancreatic Ductal Adenocarcinoma; Early Detection Initiative (EDI) for Pancreatic Cancer
Lead sponsor
Pancreatic Cancer Action Network
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 14, 2021
Completion date
January 31, 2028
Enrollment
8,869 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, hyperglycemia, pancreas ductal adenocarcinoma